Serum biomarkers evaluation to predict chemotherapy-induced cardiotoxicity in breast cancer patients
出版年份 2015 全文链接
标题
Serum biomarkers evaluation to predict chemotherapy-induced cardiotoxicity in breast cancer patients
作者
关键词
Breast cancer, Chemotherapy, Anthracicline, Taxanes, Trastuzumab, Cardiotoxicity
出版物
TUMOR BIOLOGY
Volume 37, Issue 3, Pages 3379-3387
出版商
Springer Nature
发表日期
2015-10-08
DOI
10.1007/s13277-015-4183-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Major Cardiac Events and the Value of Echocardiographic Evaluation in Patients Receiving Anthracycline-Based Chemotherapy
- (2015) Lin Wang et al. AMERICAN JOURNAL OF CARDIOLOGY
- New biomarkers for early detection of cardiotoxicity after treatment with docetaxel, doxorubicin and cyclophosphamide
- (2015) W. van Boxtel et al. BIOMARKERS
- Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients
- (2015) Christof Vulsteke et al. BREAST CANCER RESEARCH AND TREATMENT
- Trastuzumab interruption and treatment-induced cardiotoxicity in early HER2-positive breast cancer
- (2015) Anthony F. Yu et al. BREAST CANCER RESEARCH AND TREATMENT
- Cardiac Monitoring During Adjuvant Trastuzumab-Based Chemotherapy Among Older Patients With Breast Cancer
- (2015) Mariana Chavez-MacGregor et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiotoxicity of anticancer treatments
- (2015) Michael S. Ewer et al. Nature Reviews Cardiology
- Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms
- (2015) Luc Rochette et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Cardiotoxicity due to Chemotherapy: the Role of Biomarkers
- (2015) Patrick L. Stevens et al. Current Cardiology Reports
- Cancer Treatment–Related Cardiotoxicity: Current State of Knowledge and Future Research Priorities
- (2014) Nonniekaye Shelburne et al. JNCI-Journal of the National Cancer Institute
- Cardio-Oncology: Role of Echocardiography
- (2014) Hector R. Villarraga et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Heart Failure and Breast Cancer Therapies: Moving Towards Personalized Risk Assessment
- (2014) Sanjeev A. Francis et al. Journal of the American Heart Association
- High-sensitivity troponin T as a marker to predict cardiotoxicity in breast cancer patients with adjuvant trastuzumab therapy
- (2014) Kenichi Katsurada et al. SpringerPlus
- Cardiovascular Toxicities from Systemic Breast Cancer Therapy
- (2014) Shuang Guo et al. Frontiers in Oncology
- Serum Biomarkers for the Detection of Cardiac Toxicity after Chemotherapy and Radiation Therapy in Breast Cancer Patients
- (2014) Sibo Tian et al. Frontiers in Oncology
- Cardiac Biomarkers, Cardiotoxicity, and Active Collaboration
- (2013) Daniel J. Lenihan JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab
- (2013) Bonnie Ky et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Measurement of Novel Biomarkers to Predict Chronic Heart Failure Outcomes and Left Ventricular Remodeling
- (2013) Shweta R. Motiwala et al. Journal of Cardiovascular Translational Research
- Relationship between CT Findings and the Plasma Levels of Brain Natriuretic Peptide in 29 Patients with Acute Cardiogenic Pulmonary Edema
- (2012) Kosaku Komiya et al. ACADEMIC RADIOLOGY
- Long-term heart function after adjuvant epirubicin chemotherapy for breast cancer
- (2012) Jon M. Appel et al. ACTA ONCOLOGICA
- Serum NT-proBNP in the early detection of doxorubicin-induced cardiac dysfunction
- (2012) Annop Kittiwarawut et al. Asia-Pacific Journal of Clinical Oncology
- Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab
- (2012) Heloisa Sawaya et al. Circulation-Cardiovascular Imaging
- Multiple Biomarkers for Risk Prediction in Chronic Heart Failure
- (2012) Bonnie Ky et al. Circulation-Heart Failure
- Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study
- (2012) E. J. A. Bowles et al. JNCI-Journal of the National Cancer Institute
- Troponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib
- (2011) P. G. Morris et al. CLINICAL CANCER RESEARCH
- Biologic Variation of a Novel Cardiac Troponin I Assay
- (2011) V. C. Vasile et al. CLINICAL CHEMISTRY
- Cardiovascular Risk Factors in Adult Survivors of Pediatric Cancer--A Report from the Childhood Cancer Survivor Study
- (2010) L. R. Meacham et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation
- (2010) Daniela Cardinale et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiotoxicity associated with trastuzumab treatment of HER2+ breast cancer
- (2009) Manuela Fiúza ADVANCES IN THERAPY
- Use of N-Terminal Pro-Brain Natriuretic Peptide to Assess Left Ventricular Function after Adjuvant Doxorubicin Therapy in Early Breast Cancer Patients
- (2009) Timucin Cil et al. CLINICAL DRUG INVESTIGATION
- Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention
- (2009) Adriana Albini et al. JNCI-Journal of the National Cancer Institute
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now